Condition: Breast Cancer · Sponsor: Exact Sciences Corporation
The EXActDNA-003 study will prospectively enroll participants who are planning to undergo chemotherapy for high-risk, early breast cancer, who are willing to provide tissue and blood specimens for circulating tumor DNA (ctDNA) analysis. Participants will be followed for up to 5.5 years.
This description comes directly from the study's public registry record.
NSABP Department of Site and Study Management Department of Site and Study Management · 1-800-270-3165 · industry.trials@nsabp.org
Always discuss trial participation with your own doctor first.
| Katmai Oncology Group - Anchorage | Anchorage, Alaska, United States | Recruiting |
| Stanford Cancer Institute | Palo Alto, California, United States | Recruiting |
| Harbor-UCLA Medical Center - Hematology / Oncology | Torrance, California, United States | Recruiting |
| Kaiser Permanente Medical Center | Vallejo, California, United States | Recruiting |
| UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center | Aurora, Colorado, United States | Recruiting |
| AdventHealth East Altamonte Oncology and Hematology | Altamonte Springs, Florida, United States | Recruiting |
| Mount Sinai Medical - Comprehensive Cancer Center | Miami Beach, Florida, United States | Recruiting |
| Baptist Cancer Care - Plantation | Plantation, Florida, United States | Recruiting |
| St. Joseph's Women's Hospital | Tampa, Florida, United States | Recruiting |
| Rush Cancer Center | Chicago, Illinois, United States | Recruiting |
| Deaconess Chancellor Center for Oncology | Newburgh, Indiana, United States | Recruiting |
| University of Kansas Cancer Center | Westwood, Kansas, United States | Recruiting |
+ 46 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06401421